RECORD OPERATING PROFIT:
2.043 BILLION EUROS AT 17.4% OF SALES,Â
UP BY +7.7%
- Sales: +5.4% like-for-like*
- Strong growth in gross profit at 71.7% of sales
- Sustained investments in Research & Innovation and in Advertising and Promotional growth drivers
- Net profit after non-controlling interests: +5.2%
- EPS**: +7.1%, at 2.94 euros
Commenting on the figures, Mr Jean-Paul Agon, Chairman and Chief Executive Officer of L'OrÃ©al, said:
"In the first half, in a market whose growth slowed down slightly, L'OrÃ©al has continued to record good sales dynamics, and achieved further growth in profits.
The Group's competitiveness has improved once again, and is reflected in market share gains across all divisions and zones. Operating profit has reached a historically high level, with a good quality gross profit and an ongoing policy of sustained investments in Research & Innovation and in Advertising and Promotional growth drivers.
These performances demonstrate the relevance of our business model and the quality of our fundamentals: the ability of our research to create major innovations and stimulate the market, and the vitality and quality of our brand portfolio. We are thus ambitious and optimistic as we continue to implement our strategy of the "universalisation of beauty" and conquer the next billion consumers.
We are confirming our targets for 2013 and remain confident in the Group's ability to once again outperform the market, and to achieve a further year of growth in sales, results and profitability."
* +4.7% based on reported figures.
** Diluted net earnings per share, based on net profit excluding non-recurring items after non-controlling interests.
A - First-half 2013 sales
- Based on reported figures, the Groupâ€™s sales, at June 30, 2013, amounted to 11.738 billion euros, an increase of +4.7%. Like-for-like, i.e. based on a comparable structure and identical exchange rates, the Lâ€™OrÃ©al sales growth was +5.4%. The net impact of changes in consolidation was +1.0%. Currency fluctuations had a negative impact of -1.7%. Growth at constant exchange rates was +6.4%.
- If the current exchange rates, i.e. â‚¬1 = $1.334 are extrapolated up to December 31, the impact of currency fluctuations on sales would be approximately -3.6% for the whole of 2013.
- The news release of July 16, 2013 details the activity for the first half of 2013. This news release is available and can be downloaded from theÂ www.loreal-finance.comÂ website.
Sales by operational division and geographic zoneÂ
|Â||2nd quarter 2013||Â||1st half 2013|
|By operational division||Â||Â||Â||Â||Â||Â|
|Professional Products||Â 779.3||Â 2.7%||Â 1.5%||Â 1,531.8||Â 1.4%||Â 0.6%|
|Consumer Products||Â 2,802.2||Â 6.1%||Â 4.7%||Â 5,723.0||Â 6.3%||Â 5.1%|
|L'OrÃ©al Luxe||Â 1,404.7||Â 5.5%||Â 5.1%||Â 2,826.8||Â 6.4%||Â 6.6%|
|Active Cosmetics||Â 409.5||Â 8.6%||Â 7.2%||Â 907.1||Â 7.8%||Â 6.6%|
|Cosmetics total||Â 5,395.7||Â 5.6%||Â 4.5%||Â 10,988.7||Â 5.7%||Â 4.9%|
|By geographic zone||Â||Â||Â||Â||Â||Â|
|Western Europe||Â 1,908.5||Â 1.7%||Â 1.3%||Â 3,899.0||Â 1.7%||Â 1.6%|
|North America||Â 1,371.7||Â 4.5%||Â 4.9%||Â 2,743.2||Â 5.4%||Â 6.7%|
|New Markets, of which:||Â 2,115.4||Â 10.3%||Â 7.3%||Â 4,346.6||Â 9.9%||Â 7.0%|
|Asia, Pacific||Â 1,051.8||Â 8.2%||Â 4.5%||Â 2,240.2||Â 8.0%||Â 5.1%|
|Latin America||Â 507.7||Â 15.2%||Â 13.2%||Â 966.3||Â 13.5%||Â 9.6%|
|Eastern Europe||Â 355.4||Â 7.5%||Â 5.1%||Â 745.1||Â 8.4%||Â 6.7%|
|Africa, Middle East||Â 200.6||Â 15.1%||Â 12.8%||Â 394.9||Â 15.1%||Â 12.3%|
|Cosmetics total||Â 5,395.7||Â 5.6%||Â 4.5%||Â 10,988.7||Â 5.7%||Â 4.9%|
|The Body Shop||Â 186.9||Â -0.8%||Â -3.4%||Â 368.8||Â 0.5%||Â -1.4%|
|Dermatology(1)||Â 223.9||Â 0.8%||Â 4.2%||Â 380.6||Â 0.3%||Â 3.3%|
|Group total||Â 5,806.5||Â 5.2%||Â 4.2%||Â 11,738.1||Â 5.4%||Â 4.7%|
(1) Group share, i.e. 50%.
B - First-half 2013:Â
The half-year consolidated accounts have undergone a limited examination by the Statutory Auditors.
1) Operating profitability at 17.4% of sales
Consolidated profit and loss account: from sales to operating profit.
|In â‚¬m||06/30/12||% sales||12/31/12||% sales||06/30/13||% sales||Growth 06/30/12 06/30/13|
|Sales||Â 11,213.2||100.0%||Â 22,462.7||100.0%||Â 11,738.1||100.0%||+4.7%|
|Cost of sales||Â -3,247.2||29.0%||Â -6,587.7||29.3%||Â -3,318.7||28.3%||+2.2%|
|Gross Profit||Â 7,966.0||71.0%||Â 15,875.0||70.7%||Â -8,419.4||71.7%||+5.7%|
|R&D expenses||Â -386.5||3.4%||Â -790,5||3.5%||Â -420.3||3.6%||+8.8%|
|Advertising and promotion expenses||Â -3,403.6||30.4%||Â -6,776.3||30.2%||Â -3,544.2||30.2%||+4.1%|
|Selling, general and administrative expenses||Â -2,279.4||20.3%||Â -4,610.9||20.5%||Â -2,411.9||20.5%||+5.8%|
|Operating profit||Â 1,896.5||16.9%||Â 3,697.3||16.5%||Â 2,042.9||17.4%||+7.7%|
Gross profit, at 8,419 million euros, came out at 71.7% of sales, compared with 71.0% in the first half of 2012, representing an improvement of 70 basis points.
Research and Development expenses increased from 3.4% to 3.6% as a percentage of sales, and have grown by 8.8%. This increase reflects the Group's constant determination to support its investments in Research and Innovation.
Advertising and promotion expenses came out at 30.2% of sales, which is the same as the figure for the first half of 2012 at constant exchange rates and scope of consolidation.
Selling, general and administrative expenses, at 20.5% of sales, were slightly higher, by 20 basis points, than in the first half of 2012.
Operating profit grew by 7.7%, with a further 50 basis point improvement in profitability, and amounted to 17.4% of sales, which is a record level for a half-year.Â
2) Operating profit by branch and division
|Â||â‚¬m||% sales||Mâ‚¬||% sales||Mâ‚¬||% sales|
|By operational division||Â||Â||Â||Â||Â||Â|
|Professional Products||Â 303.2||19.9%||Â 615.2||20.5%||Â 307.3||20.1%|
|Consumer Products||Â 1,081.7||19.9%||Â 2,050.8||19.1%||Â 1,190.2||20.8%|
|L'OrÃ©al Luxe||Â 517.2||19.5%||Â 1,077.0||19.3%||Â 566.2||20.0%|
|Active Cosmetics||221.9||26.1%||Â 311.2||20.4%||Â 247.9||27.3%|
|Cosmetics divisions total||Â 2,123.9||20.3%||Â 4,054.3||19.5%||Â 2,311.6||21.0%|
|Non-allocated*||Â -279.7||-2.7%||Â -577.2||-2.8%||Â -294.8||-2.7%|
|Cosmetics branch total||Â 1,844.2||17.6%||Â 3,477.1||16.7%||Â 2,016.8||18.4%|
|The Body Shop||Â 11.6||3.1%||Â 77.5||9.1%||Â 9.8||2.7%|
|Dermatology branch**||Â 40.7||11.0%||Â 142.6||17.9%||Â 16.2||4.3%|
|Group||Â 1,896.5||16.9%||Â 3,697.3||16.5%||Â 2,042.9||17.4%|
* Non-allocated = Central Group expenses, fundamental research expenses, stock option and free grant of shares expenses and miscellaneous items. As a % of cosmetics sales.
** Group share, i.e. 50%.
The profitability rates of each of the Divisions improved during the first half:
The profitability of Professional Products Division increased from 19.9% to 20.1%, in a difficult market context.
The profitability of the Consumer Products Division increased from 19.9% to 20.8%, that of L'OrÃ©al Luxe from 19.5% to 20.0%, and that of the Active Cosmetics Division from 26.1% to 27.3%.
The profitability of the cosmetics branch, at 18.4%, grew by 80 basis points in the first half.
The profitability of The Body Shop, which is mainly achieved in the second half, came out at 2.7% in the first half.
Dermatology, whose profitability is traditionally stronger in the second half of each year, came out at 4.3%.Â
3) Net earnings per share**: 2.94 euros
Consolidated profit and loss account: from operating profit to net profit excluding non-recurring items.
|In â‚¬m||06/30/12||12/31/12||06/30/13||% change |
|Operating profit||Â 1,896.5||Â 3,697.3||Â 2,042.9||+7.7%|
|Financial revenues and expenses excluding dividends received||Â -4.7||Â -11.0||Â -18.0||Â|
|Sanofi dividends||Â 313.3||Â 313.4||Â 327.5||Â|
|Profit before tax excluding non-recurring items||Â 2,205.2||Â 3,999.7||Â 2,352.4||Â|
|Income tax excluding non-recurring items||Â -545.0||Â 1,025.3||Â -560.8||Â|
|Non-controlling interests||Â -1.6||Â -2.7||Â -1.7||Â|
|Net profit excluding non-recurring items after non-controlling interests*||Â 1,658.6||Â 2,971.7||Â 1,789.9||+7.9%|
|Net EPS ** (â‚¬)||Â 2.75||Â 4.91||Â 2.94||+7.1%|
|Net profit after non-controlling interests||Â 1,625.2||Â 2,867.7||Â 1,708.9||+5.2%|
|Diluted net EPS after non-controlling interests (â‚¬)||Â 2.69||Â 4.74||Â 2.81||Â|
|Diluted average number of shares||Â 603,384,895||Â 605,305,458||Â 607,829,132||Â|
* Net profit excluding non-recurring items after non-controlling interests does not include capital gains and losses on disposals of long-term assets, impairment of assets, restructuring costs, as well as competition litigation, and tax effects or non-controlling interests.
** Diluted net earnings per share excluding non-recurring items after non-controlling interests.
Overall finance costs amounted to 18.0 million euros, compared with 4.7 million euros in the first half of 2012. This increase is mainly the result of the restatement of the financial component of the retirement expense in the financial cost and of the modification of the IAS 19 standard on employee benefits schemes.
The dividends received from Sanofi amounted to 327.5 million euros.
Income tax excluding non-recurring items amounted to 560.8 million euros, representing a rate of 23.8%, slightly below the rate for the first half of 2012, which was 24.7%.
Net profit excluding non-recurring items after non-controlling interests came out at 1,789.9 million euros, up by 7.9%.
Net EPS amounted to 2.94 euros, an increase of 7.1%.
Net profit after allowing for non-recurring items and after non-controlling interestsÂ amounted to 1,708.9 million euros, an increase of 5.2%.Â
4) Operating cash flow and balance sheet
Gross cash flow amounted to 2,115 million euros; an increase of 7.8% compared with the first half of 2012.
The change in working capital increased significantly, as it does in the first half of each year, reflecting the seasonality of our business. In the first half of 2013, the increase was slightly below the figure for the first half of 2012.
Investments amounted to 524 million euros, that is 4.5% of sales.
Total cash flow from operating activities came out at 943 million euros, an increase of 22.7%.
Finally, after payment of the dividend and acquisitions, consisting mainly of the acquisition of Vogue in Colombia, of the Beauty business of Interconsumer Products in Kenya and of Spirig at Galderma, the residual cash flow came out at -1,017 million euros.
At June 30, 2013, net cash was positive at 572 million euros.
The balance sheet structure is particularly robust, as shareholders' equity represents approximately 71% of total assets.Â
5) Post-closing eventÂ
On August 15, 2013, L'OrÃ©al and Magic Holdings International Limited have announced L'OrÃ©al's proposal to acquire all of the shares of Magic Holdings International Limited, a company listed in the Hong Kong Stock Exchange. The proposed price is 6.30 HK dollars per share.
L'OrÃ©al's proposal is supported by Magic's Board of Directors. Six key shareholders, representing 62.3% of the company's equity, are already committed to supporting L'OrÃ©al's proposal.
The implementation of the transaction is subject to the approval of the Ministry of Commerce of the People's Republic of China (MOFCOM).
A specialist in cosmetic facial masks, Magic's turnover in 2012 was approximately 150 million euros. Facial masks are one of China's beauty market's fastest growing areas with very promising development prospects. Magic's MG brand is one of China's leading brands in this category.Â
ÂThis paragraph is not intended to and does not constitute, or form part of, any offer to sell or subscribe for or an invitation to purchase or subscribe for any securities or the solicitation of any vote or approval in any jurisdiction pursuant to the above mentioned proposal or otherwise, nor shall there be any sale, issuance or transfer of securities of Magic Holdings International Limited in any jurisdiction in contravention of applicable law. The proposal, if made, will be made solely through the Scheme Document, which will contain the full terms and conditions of the proposal, including details of how to vote in favour of the proposal and restrictions applicable to the proposal. Any response to the proposal, acceptance included, should be made only on the basis of information in the Scheme Document or any other document by which the Proposal is made, as the case may be.
"This news release does not constitute an offer to sell, or a solicitation of an offer to buy L'OrÃ©al shares. If you wish to obtain more comprehensive information about L'OrÃ©al, please refer to the public documents registered in France with the AutoritÃ© des MarchÃ©s Financiers, also available in English on our Internet siteÂ www.loreal-finance.com.
This news release may contain some forward-looking statements. Although the Company considers that these statements are based on reasonable hypotheses at the date of publication of this release, they are by their nature subject to risks and uncertainties which could cause actual results to differ materially from those indicated or projected in these statements."
This a free translation into English of the First-half 2013 results press release issued in the French language and is provided solely for the convenience of English speaking readers. In case of discrepancy, the French version prevails.Â
Contacts at L'OrÃ©al
Individual shareholders and market authorities
Mr Jean RÃ©gis CAROF
Tel.: +33 1 47 56 83 02
Financial analysts and institutional investorsÂ
Mrs FranÃ§oise LAUVIN
Tel.: +33 1 47 56Â 86Â 82
Mrs Stephanie CARSON-PARKER
Tel.: +33 1 47 56 76 71
Tel.: +33 1 47 56 70 00
For more information, please contact your bank, broker or financial institution (I.S.I.N. code: FR0000120321), and consult your usual newspapers, and the Internet site for shareholders and investors,Â www.loreal-finance.com,Â or call +33 1 40 14 80 50.